Literature DB >> 11375580

p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.

M Löhr1, P Müller, J Mora, B Brinkmann, C Ostwald, A Farré, F Lluis, U Adam, J Stubbe, F Plath, H Nizze, U T Hopt, M Barten, G Capellá, S Liebe.   

Abstract

BACKGROUND: Mutations in p53 and ras genes are frequent in pancreatic carcinoma. Several ras mutations are consistently detected in the pancreatic juice from patients with chronic pancreatitis. The p53 gene mutations have been detected occasionally in chronic pancreatitis tissue. It was the aim of this study to evaluate the presence and clinical significance of p53 and ras mutations in clinical pancreatic juice samples from patients with chronic pancreatitis.
METHODS: Pancreatic juice was obtained from 66 patients with chronic pancreatitis and no evidence of pancreatic carcinoma (51 men, 15 women; age 17-86 years [mean 49.6 +/- 12.9]). Patients were followed prospectively for 26 +/- 3 (4-54) months. Detection of p53 gene mutations was by temperature gradient gel electrophoresis (TGGE) and single strand conformation polymorphism (SSCP) for exons 5-8. Analysis of ras mutations was performed by SSCP/polymerase chain reaction, restriction fragment length polymorphism/polymerase chain reaction. All mutations were confirmed by sequencing.
RESULTS: Five of 66 (7.5%) pancreatic juice samples contained p53 mutations, and ras mutations were detected in 6 cases (9%). Cytology was negative in all cases. No pancreatic carcinoma developed during follow-up and neither cancer cells nor preneoplastic lesions could be detected histologically in resected specimens. Although no correlation between p53 mutations and duration of pancreatitis or drinking habits was found, K-ras mutations correlated with both heavy smoking and severity of the disease.
CONCLUSION: p53 and ras mutations can be detected in a minority of pancreatic juice samples from patients with chronic pancreatitis in the absence of malignancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375580     DOI: 10.1067/mge.2001.112711

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  15 in total

Review 1.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

2.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

4.  Evidence-based clinical practice guidelines for chronic pancreatitis 2015.

Authors:  Tetsuhide Ito; Hiroshi Ishiguro; Hirotaka Ohara; Terumi Kamisawa; Junichi Sakagami; Naohiro Sata; Yoshifumi Takeyama; Morihisa Hirota; Hiroyuki Miyakawa; Hisato Igarashi; Lingaku Lee; Takashi Fujiyama; Masayuki Hijioka; Keijiro Ueda; Yuichi Tachibana; Yoshio Sogame; Hiroaki Yasuda; Ryusuke Kato; Keisho Kataoka; Keiko Shiratori; Masanori Sugiyama; Kazuichi Okazaki; Shigeyuki Kawa; Yusuke Tando; Yoshikazu Kinoshita; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-01-04       Impact factor: 7.527

5.  KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.

Authors:  James R Eshleman; Alexis L Norris; Yoshihiko Sadakari; Marija Debeljak; Michael Borges; Colleen Harrington; Elaine Lin; Aaron Brant; Thomas Barkley; J Alejandro Almario; Mark Topazian; James Farrell; Sapna Syngal; Jeffrey H Lee; Jun Yu; Ralph H Hruban; Mitsuro Kanda; Marcia Irene Canto; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-04       Impact factor: 11.382

6.  APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors.

Authors:  Mireia M Ginesta; Zamira Vanessa Diaz-Riascos; Juli Busquets; Núria Pelaez; Teresa Serrano; Miquel Àngel Peinado; Rosa Jorba; Francisco Javier García-Borobia; Gabriel Capella; Joan Fabregat
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

7.  Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia.

Authors:  Mitsuro Kanda; Yoshihiko Sadakari; Michael Borges; Mark Topazian; James Farrell; Sapna Syngal; Jeffrey Lee; Ihab Kamel; Anne Marie Lennon; Spencer Knight; Sho Fujiwara; Ralph H Hruban; Marcia Irene Canto; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

Review 8.  Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

Authors:  De-Qing Mu; You-Shu Peng; Qiao-Jian Xu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 9.  Basic principles and technologies for deciphering the genetic map of cancer.

Authors:  Georgios Voidonikolas; Stephanie S Kreml; Changyi Chen; William E Fisher; F Charles Brunicardi; Richard A Gibbs; Marie-Claude Gingras
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

10.  Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.

Authors:  Mitsuro Kanda; Spencer Knight; Mark Topazian; Sapna Syngal; James Farrell; Jeffrey Lee; Ihab Kamel; Anne Marie Lennon; Michael Borges; Angela Young; Sho Fujiwara; Junro Seike; James Eshleman; Ralph H Hruban; Marcia Irene Canto; Michael Goggins
Journal:  Gut       Date:  2012-08-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.